$241.46 B
Share price
Change (1 day)
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Cash on Hand

Cash on Hand as of December 2022 : $9.22 B

According to AbbVie's latest financial reports the company has $9.22 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AbbVie - Cash on Hand chart (from 2011 to 2022)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31$9.22 B-6.11%
2021-12-31$9.83 B15.93%
2020-12-31$8.47 B-78.76%
2019-12-31$39.92 B395.27%
2018-12-31$8.06 B-17.65%
2017-12-31$9.78 B52.41%
2016-12-31$6.42 B-23.6%
2015-12-31$8.40 B0.39%
2014-12-31$8.37 B-15.37%
2013-12-31$9.89 B24.06%
2012-12-31$7.97 B1120.35%
2011-12-31$0.65 B5965.72%
2010-12-31$10.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$22.73 B 146.31%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.66 B-60.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$31.56 B 241.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.04 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.20 B-21.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.99 B-2.54%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.46 B-29.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$8.64 B-6.38%๐Ÿ‡ฌ๐Ÿ‡ง UK
$0.89 B-90.31%๐Ÿ‡บ๐Ÿ‡ธ USA